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Biodegradable macroporous scaffold with nano-crystal surface 
microstructure for highly effective osteogenesis and 
vascularization 
Linyang Chu,a Guoqiang Jiangb, Xi-Le Hu,c Tony D. James,d Xiao-Peng He,c* Yaping Lib* and Tingting 
Tanga* 
Using the hydrothermal calcination method, bovine cancellous bone was transformed into a degradable macroporous 
scaffold with a nano-crystal surface microstructure, capable of releasing bioactive ions. Compared with the control group, 
the presence of the nano-crystal microstructure of the material scaffold significantly promoted the gene expression of 
adhesion proteins including integrin and vinculin, thus facilitating attachment, spreading, proliferation and focal adhesions 
formation of MC3T3-E1 cells on the surface of the scaffold. Additionally, the release of active magnesium and calcium ions 
from the scaffold promoted expression of osteogenic genes and formation of calcium nodules in osteoblasts. Both in vitro 
and in vivo assays demonstrated that the three-dimensional interconnected porous architecture promoted vascularization 
and tissue integration. Our findings provide new insight into the development of degradable macroporous composite 
materials with “three-dimensional” surface microstructures as bone substitutes or tissue engineering scaffolds with 
potential for clinical applications. 
1.Introduction 
In the design and development of bone substitute or tissue 
engineering scaffold, it is important to take into account the 
complex composition and microstructure of mineralized human 
tissues.1-3 An ideal material for bone repairing or regeneration 
should be biocompatible, biodegradable, and bioactive for 
osteogenesis and vascularization. This requires the construction 
of well interconnected three-dimensional structures and 
bioactive surfaces to facilitate the migration, adhesion and 
proliferation of bone cells.4-7 In addition, bone substitutes or 
scaffolds should be degradable over time to provide space for 
bone and blood vessel growth.8-11 
Hydroxyapatite (HA, Ca5(PO4)3(OH)) and β-TCP (Ca3(PO4)2) are 
widely used bone repairing materials in clinical medicine 
because of their recognized compatibility and 
osteoconductivity. However, HA is very stable in the body, 
which compromises the balance between bone growth and 
material degradation.12 β-TCP is much more degradable than 
HA in vivo, but the unpredictable degradation rate and low 
mechanical stability limit its real application in bone 
regeneration.13, 14 To overcome these problems, multiphase 
bio-composite materials produced by a variety of techniques 
have been developed as bone substitute with well-balanced 
surface structure, pore size and connectivity, as well as 
degradation rate.15, 16 
 
Scheme 1. Schematic illustration of the degradable macroporous scaffold with nano-
crystal surface microstructure and capable of releasing bioactive ions. Both in vitro and 
in vivo assays were used to evaluate the cytocompatibility, osteogenesis, vascularization 
and tissue integration of the scaffold. 
Herein, we have used the hydrothermal calcination method 
to achieve the conversion of bovine cancellous bone (HA as 
main ingredient) into degradable macroporous scaffold 
(HA/Ca/Mg). After hydrothermal reaction with additions of 
Mg2+, PO43- and SO42-, the composite material retained its 
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original three-dimensional interconnected porous structure. 
Most importantly, nano-crystal, whisker microstructure was 
formed on the surface, which significantly improved the cell 
attachment and proliferation. Furthermore, the multiphase 
composite is degradable, capable of releasing bioactive Mg2+ 
and Ca2+ ions in microenvironment. The Mg2+ and Ca2+ ions are 
essential elements in human body and participate in many 
important metabolic activities.17 It has been shown that Mg2+ 
and Ca2+ ions can effectively promote osteogenesis during bone 
repairing.18, 19 Since a bone substitute or scaffold should also be 
in favor of vascularization accelerating formation of new bones, 
here the vascularization of the material developed was also 
investigated systematically in vitro and in vivo. We believe that 
our composite material developed with a special, “three-
dimensional” surface microstructure and the ability to release 
bioactive components will be a promising class of bone 
substitute and tissue engineering scaffold. 
 
2. Experimental Section 
2.1 Materials 
Bovine bone from femoral condylar cancellous bone were cut 
into raw bones, which then were placed in autoclave for heating 
about 40-60min at 115°C. Then the resulting material was 
cleaned with ultrasound 4-5 times. The treated raw bones were 
calcined at 800°C for 6h. After cooling, a macroporous scaffold 
was obtained. A compound solution including Mg2+, PO43- and 
SO42- was prepared with ion concentrations of 0.075mol/L, 
0.1mol/L and 0.4mol/L, respectively. The calcined bone and 
compound solution were mixed with a mass/volume rate of 
100mg/mL for hydrothermal reaction of 36h at 75°C. Then the 
scaffold was taken out and dried at 100°C for 24h. Finally, the 
scaffold was placed in temperature-controlled calcination 
furnace at 1050°C (temperature rise rate was 2.5°C/min) for 6h 
to produce the desired macroporous HA/Ca/Mg composite. HA 
calcined bone without hydrothermal reaction and that 
hydrothermally reacted in Mg2+ and PO43- solution (HA/Mg) 
were produced by the same protocol as controls. All specimens 
were sterilized by ethylene oxide for 3h before cellular and 
animal test. 
 
2.2 Composition and surface characteristics 
The composition of scaffolds was analyzed using X-ray 
diﬀraction (XRD, Japan). The scaffolds were dried through an 
ethanol series, coated by gold sputtering, and examined using a 
scanning electron microscope (SEM, Japan) at an electron 
acceleration voltage of 1.5kV in secondary electron detection 
mode. The element distribution of scaffolds was determined 
using energy dispersive spectroscopy (EDS, Japan) at an 
electron acceleration voltage of 1.5 kV. 
 
2.3 Microstructure measurement 
The three-dimensional structure, porosity, pore connectivity 
and average pore size of the scaffolds were evaluated using a 
high-resolution micro-CT (μCT, Switzerland) at an isometric 
resolution of 25μm; data were analyzed by procedures of micro-
CT (RATOC, TRI/3D-bone). 
 
2.4 Degradation test in vitro 
The degradation of test was carried out by previously reported 
study methods.20 Briefly, the scaffolds were immersed into 
50mM Tris-HCl solution at pH 7.40, 37°C maintaining a weight-
to-volume ratio of 0.2g/mL with a shaking speed at 100 r/min. 
At different time point, the scaffolds were removed and cleaned 
with deionized water, dried at 90°C for 24h. The scaffolds were 
re-immersed into fresh Tris-HCl solution with the same 
condition. This process was repeated over a period of 4 weeks. 
The percentage of degradation was calculated by the following 
equation: 
Degradation (%) = 100 × (W0 − Wt)/W0 
where W0 is the initial weight of materials and Wt is the weight 
after treatment over time (t). 
At each time point (6, 12, 24, 72 and 168h), the scaffolds were 
taken out, and the concentration of Mg2+, Ca2+ and PO43- in Tris-
HCl solution were estimated using an inductively coupled 
plasma optical emission spectrometer (ICP-OES, USA). 
Meanwhile, the scaffolds were immersed into Dulbecco’s 
Modified Eagle’s Medium at same weight-to-volume ratio and 
dissolution conditions mentioned above. At each time point, 
the pH values were measured using a flat membrane 
microelectrode (PB-10, Germany). All experiments were run in 
triplet. 
 
2.5 Evaluation of cytocompatibility in vitro 
2.5.1 Cell spreading and focal adhesions formation 
HA, HA/Mg, and HA/Ca/Mg scaffolds (column, 10×2mm) were 
placed in 24-well plates. We chose the MC3T3-E1 cells,21 a 
mouse preosteoblast line derived from mouse calvaria, since 
they have better stability in differentiation and cell phenotype, 
and less individual variation than human derived stem cells; 
these merits may lead to better reproducibility in 
experimentation. The cell suspension was seeded at a density 
of 3.0×104/cm2 for each well. To assess cell spreading and focal 
adhesions formation after 6 h culturing, SEM and fluorescence 
staining were used. Briefly, cells were cultured on scaffolds for 
6h, fixed with 2.5% glutaraldehyde for 15min, and then washed 
three times with PBS. Next, the samples for SEM analysis were 
treated in the same way as the above. Meanwhile, for 
fluorescence staining, cells on scaffolds were fixed with 4% 
paraformaldehyde for 15min, permeabilized with 0.1% Triton X-
100 in PBS for 10min and blocked with 5% albumin from bovine 
serum albumin (BSA). Then rabbit monoclonal antibody to 
vinculin (ab196454, Abcam) were used to stain the focal 
adhesions. Simultaneously, 4,6-diamidino-2-phenylindole 
(DAPI, Sigma) was used to stain the cell nuclei and rhodamine 
phalloidin (Molecular Probe, Cytoskeleton) was used to stain 
the filamentous actin of the cytoskeleton. At last the samples 
were observed by confocal laser scanning microscopy (CLSM, 
Germany). 
To study the focal adhesions formation, intracellular integrin 
β1 and vinculin protein levels at 6h were semi-quantitatively 
analyzed by western blotting. Collected proteins were 
separated using 8% SDS-PAGE gel, transferred onto PVDF 
membrane, and blocked with 5% skim milk solution for 1h at 
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room temperature. The samples were incubated with primary 
antibodies overnight and then incubated with an HRP-
conjugated secondary antibody. Luminescence was detected 
and quantified by an imaging system (ChemiScope3600MINI, 
China). GAPDH was used as a loading control. 
 
2.5.2 Cell attachment, viability and proliferation 
As described above, the cells were co-cultured with the material 
in 24-well plates. The cell counting kit-8 (CCK-8) assay was used 
to analyze cell attachment at 6 and 12h, and to analyze cell 
viability and proliferation at the time points of 1, 4 and 7d. The 
modified OD values at 4 and 7d were normalized to those at 1d 
to calculate the proliferation rate of cells. In addition, 
fluorescence staining was used to observe cell viability on 
scaffolds at 1d. DAPI and rhodamine phalloidin were used to 
stain the cell nuclei and cytoskeleton. Cells were imaged by 
CLSM. 
 
2.6 Osteogenic differentiation in vitro 
2.6.1 Cell culture and preparation of osteogenic inductive 
extraction 
Extraction medium of HA, HA/Mg, and HA/Ca/Mg scaffolds 
were prepared according to the International Organization for 
Standardization method (ISO 10993-12).22 Briefly, the scaffolds 
were incubated in standard culture medium at a mass/volume 
ratio of 100mg/mL at 37°C. After 24h, the supernatant was 
carefully collected and added with osteogenic inductive 
supplements, including 100nM dexamethasone (Sigma), 
50μg/mL ascorbic acid (Sigma) and 10mM β-glycerophosphate 
sodium (Sigma). Then the osteogenic inductive extraction was 
filter sterilized and stored at 4°C for further use. Afterwards, 
MC3T3-E1 cells were cultured with standard culture medium at 
a density of 5.0×104/cm2 in 24-well plates for 24h. Then the 
medium was changed to the osteogenic inductive extraction 
and refreshed every two days. 
 
2.6.2 ALP, alizarin red staining and relative quantitative 
analysis 
After 7, 14 and 21d of culture, ALP staining method was 
performed according to previously reported procedure.23 ALP 
activity was determined using a ALP microplate test kit 
(Beyotime, China) and observed directly by optical microscopy. 
The quantity of ALP in the cell lysates was measured at 520nm 
using the Synergy HT microplate reader (Bio-Tek), then it was 
normalized to the corresponding total protein content 
determined by a BCA protein assay kit (ThermoFisher Scientific) 
according to the provided protocol. Meanwhile, calcium 
deposition (mineralization) was assessed by Alizarin Red S 
staining.23 After culture for 21 and 28d, cells were fixed in 4% 
paraformaldehyde for 15min at 37°C prior to being stained with 
1% alizarin red solution (Sigma) for 45min. Then the samples 
were washed with PBS to remove the non-specific staining and 
observed directly by optical microscopy. For the quantitative 
analysis, 10% cetylpyridinium chloride (Sigma) in 10mM sodium 
phosphate (Sigma) was added to the stained wells and then the 
mixed solutions were measured at 620nm using the Synergy HT 
microplate reader (Bio-Tek). 
 
2.6.3 Expression of osteogenic related genes 
The mRNA expression of several osteogenic differentiation-
related genes, including osteocalcin (OCN), bone sialoprotein 
(BSP), collagen type I (COL1) and osteopontin (OPN), were 
quantitatively determined by real-time polymerase chain 
reaction (PCR).21 The transcription levels of the genes were 
normalized to the housekeeping gene GAPDH. The sequences 
of the forward and reverse primers were demonstrated in Table 
1. After 7, 14 and 21 days of culturing with the osteogenic 
inductive extraction, the TRIzol reagent (Ambion, USA) was 
used to collect total RNA according to the provided 
manufacturer’s instructions. Then, reverse transcription was 
performed following the protocol of the Revert Aid ﬁrst-strand 
cDNA synthesis kit (Fermentas, USA). Quantitative PCR (qPCR) 
was performed on an ABI 7500 machine (Applied Biosystems, 
USA) using the SYBR premix EX Taq PCR kit (Takara). 
 
Table 1 Primer sequences for real-time PCR. 
Target 
gene 
Primers (5′-3′; F = forward; R = 
reverse) 
Length 
ALP F: GGGCATTGTGACTACCACTCG 
R: CCTCTGGTGGCATCTCGTTAT 
21 
21 
COL 1 F: AACAGTCGCTTCACCTACAGC 
R: GGTCTTGGTGGTTTTGTATTCG 
21 
22 
OPN F: CTTTCACTCCAATCGTCCCTAC 
R: CCTTAGACTCACCGCTCTTCAT 
22 
22 
OCN F: GGACCATCTTTCTGCTCACTCTG 
R: TTCACTACCTTATTGCCCTCCTG 
23 
23 
GAPDH F: AGGTCGGTGTGAACGGATTTG 
R: GGGGTCGTTGATGGCAACA 
21 
19 
 
2.7 Bioactivity of vascularization in vitro 
2.7.1 Cell culture and preparation of vascularized inductive 
extraction 
Human umbilical vein endothelial cells (HUVECs) were 
purchased from Shanghai Institutes for Biological Science and 
cultured in α-minimum medium supplemented with 10% fetal 
bovine serum and 1% penicillin/streptomycin. The extracts 
medium of scaffolds, as mentioned above, was added with 1% 
ECGS (Endothelial Cell Growth Supplement, BD Biosciences). 
After that, the vascularized inductive extraction was filter 
sterilized and stored at 4 °C for use. 
 
2.7.2 Capillary connections formation assay and quantitative 
analysis of VEGF 
HUVECs were cultured in vascularized inductive extraction for 
2d. Then, Matrigel (BD Biosciences) was mixed with culture 
media at a ratio of 1:3 and added evenly to each well of a 96-
well plate. HUVECs were separately resuspended and seeded on 
the gel at a density of 2×104cells/well. After incubation for 4h at 
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37°C, the plate was observed by optical microscopy. At least 5 
fields were digitally acquired for each substrate and the total 
number of capillary connections per field were counted by a 
blinded observer using Image-Pro Plus software (Media 
Cybernetics, USA). Moreover, HUVECs were cultured in the 
vascularization inductive extraction for 12, 24 and 48h. At each 
time point, the supernatant was collected and stored at -80 °C. 
The concentration of VEGF was determined by using a Human 
Quantikine ELISA kit (R&D Systems, Canada) according to the 
manufacturer’s instructions. Briefly, the supernatant was added 
to 96-well microplates that were coated with a monoclonal 
antibody to the factor of interest and incubated for 2h. After 
washed with PBS, substrate solution was added and incubated 
for 30min, and the reaction was terminated by addition of stop 
solution. VEGF levels were determined by measurement of the 
optical density at 450nm using the Synergy HT microplate 
reader (Bio-Tek). 
 
2.8 Tissue integration and vascularization analysis in vivo 
2.8.1 Subcutaneous implantation of scaffolds in mice 
A dorsum subcutaneous implantation model was established to 
evaluate vascularization of scaffolds in vivo.24 All experimental 
procedures were approved and performed in accordance with 
the guidelines of the Animal Ethics Committee of Shanghai 
Ninth People’s Hospital (The protocol registry number: A-2016-
017). Briefly, 24 specific pathogen-free (SPF) 8-week-old male 
BALA/c mice were assigned randomly to three groups. The mice 
were initially anesthetized by using an intraperitoneal injection 
of 1% pentobarbital sodium (100mg/kg) and the left dorsum 
was shaved and cleaned with 2% iodine prior to the procedure. 
Then, a deep subcutaneous pocket was made through an 
approximately 1.5cm longitudinal skin incision over the left 
dorsum, in which one sample of a sterile scaffold was placed. 
The mice were housed in ventilated rooms and allowed to eat 
and drink after surgery. No antibiotics were administered, and 
no mortality occurred during experiment. 
 
2.8.2 Micro-CT based vascularization and histological analysis 
Microfil perfusion (Microfil MV, USA) was conducted at 28 days 
after surgery. Briefly, after the pericardial cavity of the mice was 
exposed, the right auricle was snipped, then immediately 
heparinized saline (100U/mL) was perfused into the apex of the 
heart at 2mL/min using a syringe pump. A solution of Microfil 
prepared in a volume ratio of 4/5 of Microfil/diluent with 5% 
curing agent was perfused at a rate of 2mL/min according to the 
manufacture’s protocol.24 Then implanted scaffolds were 
harvested, fixed with 4% neutral-buffered formaldehyde for 
48h and decalcified with 9% formic acid for 4 weeks. The 
vascularization of scaffolds was reconstructed using micro-CT. 
Three-dimensional reconstruction of the newly formed vessels 
and their volume within scaffolds were analyzed by the 
software provided by manufacture. The evaluation was 
obtained from four animals randomly selected in each group. 
After that, remaining scaffolds and surrounding soft tissues 
were retrieved 28 days after surgery. Then they were immersed 
in 4% neutral-buffered formaldehyde for 48h. The collected 
scaffolds and surrounding soft tissues were embedded into 
paraffin. The specimens were cut into sections parallel to the 
top surface of the scaffolds and prepared at a thickness of 5μm 
(EXAKT-400, German). Hematoxylin eosin (H&E) and Masson’s 
trichrome staining were used to assess the morphology and 
tissue integration. Furthermore, CD31 immunohistochemistry 
was used to assess vascularization. Sections were dewaxed in 
descending concentrations of alcohol and rehydrated. The 
slides were immersed in 3% hydrogen peroxide to block 
endogenous peroxidases and rinsed in PBS. They were 
immersed in 0.1% Triton-X100 in PBS for 15min to allow 
penetration of the membrane. Antigen retrieval was carried out 
in a 10mM warm citrate buffer for 15min. Specific sites were 
saturated with normal goat serum, for 40min at 37℃. Then, 
monoclonal anti-CD31 antibody (ab76533, Abcam) was used. 
The sections were incubated with biotinylated rabbit anti-rabbit 
immunoglobulins, washed in TBS for 5min and incubated for 
30min with streptavidin-peroxidase (1:50, DAKO). The nuclei 
were counter stained with H&E for two to three seconds, 
washed in distilled water and finally covered with Aqua Tex 
(Merck, Germany). Four slides were then examined 
microscopically for taking its average for statistical analysis. 
 
2.9 Statistical analysis 
All data are expressed as Mean ± SD. Nonparametric test 
(Mann–Whitney U test), one-way analysis of variance (ANOVA) 
and the least significant difference (LSD) test were utilized to 
determine the level of significance; p < 0.05 was defined as 
statistically significant, and p < 0.01 was considered highly 
statistically significant. All statistical analyses of the data were 
performed using SPSS software (v19.0, USA). 
 
3. Results and discussion 
3.1 Composition and microstructure characteristics 
 
Fig 1. Composition and surface characteristics of different scaffolds. (A) X-ray diﬀraction 
of scaffolds. (B) SEM images of the surface morphology of scaffolds. 
In this study, the hydrothermal calcination method has been 
used to convert bovine cancellous bone into multiphase, 
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degradable macroporous scaffold. The hydrothermal 
calcination process is necessary since it can remove 
immunogenic proteins and collagen, maintain the original 
three-dimensional interconnected porous structure and 
facilitate the formation of surface microstructure. The 
composition and microstructures of the different scaffolds 
constructed were first characterized by a diverse range of 
techniques. Fig.1A showed the main composition of different 
scaffolds by XRD. The results showed that HA scaffold was 
mainly composed of hydroxyapatite, in contrast, after 
calcination with hydrothermal reaction, Ca(3-n)Mgn(PO4)2 was 
produced in HA/Mg scaffold. Moreover, in HA/Ca/Mg scaffold, 
we observed that the content of Ca(3-n)Mgn(PO4)2 was relatively 
decreased along with the emergence CaSO4 signal. The surface 
morphology of three scaffolds constructed was characterized 
using SEM (Fig.1B). The images showed that the HA/Mg scaffold 
had a rougher surface than HA scaffold, which could be ascribed 
to the formation of Ca(3-n)Mgn(PO4)2 on the former surface. The 
elemental distributions of Ca, O, P, Mg, and S of different 
scaffolds obtained by EDS are shown in Fig.2A. The images 
showed that Mg and S elements existed in HA/Ca/Mg scaffold 
after hydrothermal reaction. A weaker Mg element signal was 
observed in the HA/Ca/Mg scaffold than the HA/Mg scaffold, 
which was consistent with the results of XRD analysis. 
Interestingly, after calcination we observed the formation of a 
nano-crystal, whisker-like microstructure on the surface of the 
HA/Ca/Mg scaffold (Fig.1B). Meanwhile, EDS analysis of nano-
crystal whisker on HA/Ca/Mg scaffold surface suggests that the 
composition consisted of sulfur element (Fig.2A). The results of 
XRD and EDS analyses demonstrated that the main composition 
of the nano-crystal whisker structure was CaSO4. 
 
Fig 2. Element distribution of scaffolds and 3D microstructure of HA/Ca/Mg scaffold. (A) 
Element distribution on surface of various scaffolds. (B) 3D reconstructed images, 
porosity, pore connectivity and pore size of HA/Ca/Mg scaffolds obtained using Micro-
CT.  
A bioactive scaffold should exhibit an ideal porosity with a 
homogeneous and interconnected porous structure, which is 
amenable for bone repair, vascular access and oxygen and 
tissue fluid exchange, providing physiologically active space for 
bone ingrowth.25, 26 The morphology and pore distribution of 
HA/Ca/Mg scaffold were characterized using micro-CT (Fig.2B). 
The scaffold possessed homogeneous and interconnected 
porous structures with a porosity of 82.4 ± 4.1%, connectivity of 
100% and an average pore size of 370.3 ± 37.6μm. There is no 
significant difference in the porous structures among all three 
groups. 
 
3.2 Degradation test in vitro 
Degradation rate is another important feature of bone 
substitutes and bone-tissue engineering scaffolds.27 The ability 
of a scaffold to degrade within a reasonable timeframe can offer 
space for new bone formation and blood vessel growth. 
Whereas the degradation rate of HA is thought to be too slow 
for new bone growth, too fast degradation rate would lead to 
unwanted bone defects in the implanted area.12, 13, 28, 29 The 
degradation of different scaffolds was measured in Tris-HCl 
solution. As shown in Fig.3A, the weight loss of HA/Ca/Mg 
scaffold after 4 weeks was about 21.8%, which is larger than 
that of the HA/Mg and HA group. The pH value of HA/Mg 
scaffold increased rapidly within 0-24h, and from 24 to 168h, 
the pH continued to increase slightly. The HA/Ca/Mg scaffold 
had a relatively smaller pH fluctuation during 0 to 168h. Due to 
limited degradation, the pH value of HA scaffold hardly changed 
with time. Shown in Fig.3C-E are the concentration changes of 
Mg2+, Ca2+ and PO43- released from different scaffolds. The 
concentration of Mg2+, Ca2+ and PO43- in HA/Mg and HA/Ca/Mg 
increased rapidly from 0 to 72h and began to stabilize from 72 
to 168h. In contrast, no significant changes in ion concentration 
of the HA scaffold were observed at different time points. Mg2+ 
plays a critical role in the body in mediating cell-extracellular 
matrix (ECM) interactions and controlling bone apatite 
structure and density.30,31 The HA/Ca/Mg scaffold contains 
three different main ingredients and the dissolution rate 
between the various composition was largely difference. 
Therefore, the scaffold could achieve gradient degradation, i.e. 
the material could be degraded rapidly in early stage to release 
active Mg2+, Ca2+ and PO43-, followed by a stably sustained 
degradation to offer space for new bone formation. 
 
Fig 3. Degradation test. (A) Weight loss rate of different scaffolds. (B) Changes in pH value. 
(C), (D), (E) Changes in concentration of Mg2+, Ca2+ and PO43-. 
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3.3 Cell attachment, spreading, proliferation and focal 
adhesions formation on the scaffold surface 
SEM was used to observe cell morphology on different scaffolds 
after 6h. Fig.4A showed less adherent cells on HA and HA/Mg  
 
Fig 4. Spreading and focal adhesions formation of MC3T3-E1 cells on the different 
scaffolds. (A) SEM images of cells morphology and spreading at 6h on scaffolds. (B) The 
cytoskeletal morphology and focal adhesions formation of cells at 6h on scaffolds. 
Representative images of cells stained with DAPI for cell nuclei (blue), rhodamine 
phalloidin for actin filaments (red), and monoclonal antibody for focal adhesions (green). 
For CLSM, the scale bar for the row is shown in the merge image. 
scaffolds than on the HA/Ca/Mg scaffold. In particular, on the 
HA/Ca/Mg scaffold, cells were densely adhered to the nano-
crystal whisker microstructure on which numerous filopodia 
were pervaded. From mechanism of view, excellent cell 
spreading might be caused by an increased expression of 
adhesion related proteins including integrins and vinculin, 
thereby providing mechanical forces to the material surface.32 
Integrins are a family of transmembrane receptors that provide 
anchorage force for cellular adhesion by activating intracellular 
signalling pathways after ligand binding.33 It is proven that the 
expression of integrins is dependent on structure, roughness 
and wet ability of material surface.32 Vinculin, on the other 
hand, a highly conserved actin-binding protein, is frequently 
used as a marker for focal adhesion.34 Shown in Fig.4B is the 
CLSM micrograph exhibiting cell spreading and focal adhesions 
formation on the different scaffolds. The cells grown on 
HA/Ca/Mg scaffold displayed a clustered and confluent 
morphology with extensive actin filaments linking to adjacent 
cells. In contrast, cells on HA and HA/Mg scaffolds exhibited 
dispersed morphology with fewer actin filaments and a more 
reduced level of spreading. Meanwhile, the vinculin protein was 
immune-stained in the cytoplasm (visible as a green background 
inside the cells), suggesting the formation of abundant focal 
adhesions on HA/Ca/Mg. The intracellular protein expression of 
integrin β1 and vinculin after 6h was further analyzed by 
western blotting (Fig.5A-B). The results showed that integrin β1 
and vinculin were detected at higher levels in cells grown on 
HA/Ca/Mg scaffold (p < 0.01) than other scaffolds, which 
suggested that the microstructure of HA/Ca/Mg scaffold could 
up-regulate expression of focal adhesions proteins in MC3T3-E1 
cells, in agreement with the results of CLSM. 
 
Fig 5. Adhesion related protein expression, attachment, viability and proliferation of 
MC3T3-E1 cells on the different scaffolds. (A), (B) Western blotting for analysis of integrin 
β1 and vinculin in cells cultured for 6h and the results were quantified. (C) Cell  
attachment analysis at 6 and 12h determined by CCK-8 assay. (D) Relative cell 
proliferation rates at 4 and 7d determined by CCK-8 assay. (E) Cell viability evaluated by 
fluorescence staining at 1d on scaffolds. DAPI for cell nuclei (blue) and phalloidin for actin 
filaments (red). *p＜0.05 compared with HA scaffolds. **p＜0.01 compared with HA 
scaffolds. #p＜0.05 compared with HA/Mg scaffolds. ##p＜0.01 compared with HA/Mg 
scaffolds. The scale bar for the row is shown in the merge image. 
Cell attachment on scaffolds was evaluated by CCK-8 assay 
after 6 and 12h. As shown in Fig. 5C, the counts of adherent cells 
on HA/Ca/Mg scaffold were significantly higher than that on HA 
and HA/Mg scaffolds at 6 and 12h (p < 0.05). This result suggests 
that HA/Ca/Mg scaffold could improve cell initial attachment on 
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the material surface. We deduced that the initial cell 
attachment and spreading would affect cell proliferation on the 
material surface. This deduction was proven by the following 
analysis. The relative proliferation rate of cells on different 
scaffolds was shown in Fig.5D. The cells on HA/Ca/Mg scaffold 
exhibited a higher proliferation rate than those on HA and 
HA/Mg scaffolds at 4 and 7d (p < 0.05). In addition, although the 
proliferation of cells on HA/Mg scaffold was slightly higher than 
that on HA scaffold, no significant differences were observed 
between the two scaffolds from day 1 to 7d (p > 0.05). 
Moreover, CLSM was used to observe cell viability at 1d. The 
cells stained with DAPI and phalloidine on the three scaffolds at 
1d were showed in Fig.5E, which again corroborated the higher 
cell viability on the HA/Ca/Mg scaffold than other scaffolds. 
These results confirmed that the nano-crystal microstructure 
could promote cell attachment, spreading, proliferation and 
focal adhesions formation, thus improving cytocompatibility of 
the scaffold. In our previous study,35 we demonstrated that the 
topographical and morphological features of the 
nanostructured surface could regulate cell extension and 
cytoskeleton tension by the related signalling pathway of focal 
adhesions, which is similar to the results when using a 
HA/Ca/Mg scaffold. With this study we envisioned that these 
biological effects might be related to the unique characteristics 
of the nano-crystal whisker-like structure, the nano-topological 
effect, and the enhanced adhesion protein adsorption level. 
Additional, relevant research will be carried out in the near 
future to confirm these theories. Moreover, we have already 
proven that the material’s nano-surface could regulate 
osteogenic differentiation by affecting cell adhesion.36 The cell 
adhesion mediated the activity of intracellular YAP/TAZ 
signalling by mechanotransduction, which could activate 
osteogenesis-related pathways and further promote the 
differentiation of cells. The focal adhesions formation plays a 
critical role in transformation of physical characteristics into 
biological effects. 
 
3.4 Osteogenic differentiation in vitro 
The role of bioactive Ca2+ and Mg2+ are beneficial for 
proliferation and differentiation of osteoblasts in osteogenesis 
process.8, 17, 37, 38 Moreover, extracellular PO43- can enter cells 
and subsequently the mitochondria, thereby promoting the 
synthesis of ATP. The ATP is then secreted, which can accelerate 
osteogenic differentiation of osteoblasts in bone regeneration 
by autocrine and/or paracrine signalling pathways.39 The ALP, 
Alizarin-red staining and relative quantitative analysis were 
carried out to better understand the influence of bioactive 
extraction of the scaffolds on the osteogenic differentiation of 
cells. Fig.6A-B showed the ALP and Alizarin-red intensity after 7, 
14, 21 and 28d of cell culturing. The intensity of HA/Ca/Mg 
group was considerably stronger than HA and HA/Mg groups. 
The relative ALP activity of HA/Ca/Mg group was evidently 
higher than that of the HA group at all time points (Fig.6C, p < 
0.01). The results also indicated that the calcium nodule 
formation of HA/Ca/Mg group was significantly higher than that 
on HA and HA/Mg groups at 21 and 28d (Fig.6D, p < 0.01). 
Meanwhile, we examined the expression lever of several critical 
osteogenic markers using quantitative real-time PCR assay at 7, 
14 and 21d (Fig.7A-D). At 7d, cells grown in osteogenic inductive 
extraction of HA/Ca/Mg scaffold showed higher expression 
levels of ALP and COL1 compared with other groups (p < 0.05). 
At 14d, the gene expression of COL1 and OPN reached the peak 
in all three groups, and the ALP, COL1, OPN, and OCN mRNA 
levels of HA/Ca/Mg group were significantly higher than that of 
the HA and HA/Mg groups (p < 0.05). Besides, at 21d, the 
expression of four osteogenic mRNA of HA/Ca/Mg group still 
maintained the highest level in all groups (p < 0.05). These 
results showed that osteogenic inductive extraction of 
HA/Ca/Mg scaffold could lead to a better osteogenesis ability 
than the other control scaffolds. 
 
Fig 6. Effects of osteogenic inductive extraction of scaffolds on osteogenesis of MC3T3-
E1 cells. (A) ALP staining after 7, 14 and 21d of cell culture in osteogenic inductive 
extraction. (B) Alizarin Red-S staining after 21 and 28d of cell culture in osteogenic 
inductive extraction. (C), (D) The quantitative analysis of ALP activity and alizarin Red-S 
staining. The ALP activity was normalized to the corresponding total protein content. *p
＜0.05 compared with HA scaffolds. **p＜0.01 compared with HA scaffolds. #p＜0.05 
compared with HA/Mg scaffolds. ##p＜0.01 compared with HA/Mg scaffolds. 
3.5 Bioactivity of vascularization in vitro 
Vascularization is known to provide necessary oxygen and 
nourishment for reparative cell, tissue ingrowth and bone 
reconstruction.40 It was reported that vascularization could be 
dependent on the interaction between proteins and divalent 
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ions (such as Ca2+ and Mg2+) since the divalent ions may increase 
the affinity of some protein receptors in the vascularization 
process.41 In this study, the capillary connections formation 
capability of HUVECs cultured with different vascularized 
inductive extraction was investigated by microscopy and 
quantified in terms of the number of capillary connections. 
Compared with other two groups, HUVECs cultured with 
extraction of HA/Ca/Mg scaffold after 4h on Matrigel 
demonstrated a better capillary-like network formation ability 
(Fig.7E). The number of capillary connections per field in 
HA/Ca/Mg scaffold were significantly greater per field than 
other groups (Fig.7F, p < 0.05). However, the ELISA results 
(Fig.7G, p > 0.05) illustrated that the released divalent ions did 
not affect the amount of VEGF secreted by HUVECs, which is an 
important angiogenic growth factor in the vascularization 
process.42, 43 We hypothesized that divalent ions only increased 
the sensitivity of HUVECs to VEGF, but did not promote the 
secretion of VEGF during the vascularization process. 
 
Fig 7. Expression of osteogenic related genes of MC3T3-E1 cells and vascularization 
evaluation of HUVECs. (A), (B), (C), (D) Relative mRNA expression of osteogenic 
differentiation related genes in cells grown with various osteogenic inductive extraction 
measured by real-time PCR after 7, 14 and 21d. (E) Microscopy images of capillary 
connections formation on Matrigel for 4h by HUVECs after cultured with different 
vascularized inductive extraction. (F) Total number of capillary connections formation 
per field by using Image-Pro Plus software. (G) The concentration of VEGF secreted by 
HUVECs cultured in vascularized inductive extraction for 12, 24 and 48h. *p＜0.05 
compared with HA scaffolds. **p＜ 0.01 compared with HA scaffolds. #p＜ 0.05 
compared with HA/Mg scaffolds. ##p＜0.01 compared with HA/Mg scaffolds. 
3.6 Tissue integration and Micro-CT based analysis of 
vascularization in vivo 
In tissue regeneration, vascularization can precede 
osteogenesis, and the enhanced neovascularization can 
accelerate new bone formation.44, 45 It has been demonstrated 
that angiogenesis is affected by the size of interconnected pore 
structure, which may lead to a faster vascularization and higher 
local oxygenation level.26 Three-dimensional images of 
vascularization within the subcutaneously implanted scaffolds 
in vivo were showed in Fig.8A, which indicated that more newly 
formed vessels detected within the HA/Ca/Mg scaffold 
compared with HA and HA/Mg scaffolds at 28d after 
implantation. Meanwhile, the calculated volume of the newly 
formed vessels within the HA/Ca/Mg scaffold were significantly 
larger than the other two scaffolds (Fig.8B, p < 0.05). Moreover, 
histological sections were stained with H&E and Masson’s 
trichrome to assess the soft tissue integration in vivo. As 
demonstrated in Fig.8C, the HA/Ca/Mg scaffold exhibited better 
tissue integration than HA and HA/Mg scaffolds, which 
indicated that the HA/Ca/Mg scaffold could offer a favourable 
micro-environment for tissue growth. Further, the results of 
CD31 immunohistochemistry showed a much better 
neovascularization of the HA/Ca/Mg scaffold than other 
scaffolds (Fig. 8C). These results showed that the HA/Ca/Mg 
scaffold displayed better biocompatibility in vivo after 28 days 
from implantation. 
 
Fig 8. Vascularization and tissue integration of various scaffolds in vivo. (A), (B) 
Representative 3D images of Micro-CT based newly formed vessels within scaffolds at 
28d after implantation and quantitative analysis of vessels volume. (C) Histological 
images of implanted scaffolds at 28d after implantation. H&E and Masson’s trichrome 
staining were used to assess the morphology and tissue integration. CD31 
immunohistochemistry was used to assess vascularization (blue *, scaffold; black #, 
tissue). *p＜0.05 compared with HA scaffolds. #p＜0.05 compared with HA/Mg scaffolds. 
4. Conclusion 
We used the hydrothermal calcination process to develop a 
bioactive scaffold with the original interconnected porous 
structure and novel nano-crystal whisker-like microstructures 
on the surface. Moreover, the scaffold can achieve gradient 
degradation with the capacity of releasing bioactive ions. Our 
results suggested that this scaffold with the nano-crystal 
surface effectively enhanced osteogenic cell attachment, 
spreading, proliferation and focal adhesions formation. 
Notably, the scaffold promoted the osteogenic differentiation 
of pre-osteoblasts and capillary connections formation of 
HUVECs in vitro and demonstrated vascularization and tissue 
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integration in vivo. We believe that these factors collectively 
play a synergistic effect on the biological processes. The unique 
scaffold developed herein might provide a new class of 
bioactive degradable composites as bone substitutes or tissue 
engineering scaffolds capable of osteogenesis and 
vascularization. 
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